{"entity":{"type":"insider","cik":"0001280180","url":"/insider/0001280180","json_url":"/insider/0001280180.json","name":"JACOBY PHILIP R JR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2004-08-09","last":"2015-05-29","span_basis":"filed_date"},"name_variants":[{"name":"JACOBY PHILIP R JR","source":"filing","n_filings":5,"first_seen":"2004-08-09","last_seen":"2015-05-29"}],"transactions":[{"id":8452859,"accession":"0001179110-15-008722","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-008722","line_url":"/filing/0001179110-15-008722#line-4","is_derivative":false,"issuer_cik":"0001280180","issuer_name":"OSIRIS THERAPEUTICS, INC.","issuer_ticker":"OSIR","issuer_name_source":null,"issuer_url":"/issuer/0001280180","owner_cik":"0001280180","owner_name":"JACOBY PHILIP R JR","owner_url":"/insider/0001280180","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":18.554,"price_display":"18.55","price_state":"stated","total_value":371080.0,"total_display":"371,080.00","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-27","filed_date":"2015-05-29","scope":"insider"},{"id":6213120,"accession":"0001179110-14-009000","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-009000","line_url":"/filing/0001179110-14-009000#line-4","is_derivative":false,"issuer_cik":"0001280180","issuer_name":"OSIRIS THERAPEUTICS, INC.","issuer_ticker":"OSIR","issuer_name_source":null,"issuer_url":"/issuer/0001280180","owner_cik":"0001280180","owner_name":"JACOBY PHILIP R JR","owner_url":"/insider/0001280180","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15947.0,"shares_display":"15,947","price_per_share":15.426,"price_display":"15.43","price_state":"stated","total_value":245998.422,"total_display":"245,998.42","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-21","filed_date":"2014-05-23","scope":"insider"},{"id":5327206,"accession":"0001179110-13-017041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-017041","line_url":"/filing/0001179110-13-017041#line-2","is_derivative":false,"issuer_cik":"0001280180","issuer_name":"OSIRIS THERAPEUTICS, INC.","issuer_ticker":"OSIR","issuer_name_source":null,"issuer_url":"/issuer/0001280180","owner_cik":"0001280180","owner_name":"JACOBY PHILIP R JR","owner_url":"/insider/0001280180","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18372.0,"shares_display":"18,372","price_per_share":15.9852,"price_display":"15.99","price_state":"stated","total_value":293680.0944,"total_display":"293,680.09","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-25","filed_date":"2013-11-26","scope":"insider"},{"id":325247,"accession":"0000887936-04-000053","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000887936-04-000053","line_url":"/filing/0000887936-04-000053#line-4","is_derivative":false,"issuer_cik":"0000887936","issuer_name":"FTI CONSULTING INC","issuer_ticker":"FCN","issuer_name_source":null,"issuer_url":"/issuer/0000887936","owner_cik":"0001280180","owner_name":"JACOBY PHILIP R JR","owner_url":"/insider/0001280180","role":"Officer (VP and Corporate Controller)","officer_title":"VP and Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":18.71,"price_display":"18.71","price_state":"stated","total_value":58001.0,"total_display":"58,001.00","shares_owned_after":719.0,"shares_owned_after_display":"719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-03","filed_date":"2004-11-05","scope":"insider"},{"id":325246,"accession":"0000887936-04-000053","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000887936-04-000053","line_url":"/filing/0000887936-04-000053#line-3","is_derivative":false,"issuer_cik":"0000887936","issuer_name":"FTI CONSULTING INC","issuer_ticker":"FCN","issuer_name_source":null,"issuer_url":"/issuer/0000887936","owner_cik":"0001280180","owner_name":"JACOBY PHILIP R JR","owner_url":"/insider/0001280180","role":"Officer (VP and Corporate Controller)","officer_title":"VP and Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":219.0,"shares_display":"219","price_per_share":18.77,"price_display":"18.77","price_state":"stated","total_value":4110.63,"total_display":"4,110.63","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-03","filed_date":"2004-11-05","scope":"insider"},{"id":318464,"accession":"0000887936-04-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000887936-04-000045","line_url":"/filing/0000887936-04-000045#line-1","is_derivative":false,"issuer_cik":"0000887936","issuer_name":"FTI CONSULTING INC","issuer_ticker":"FCN","issuer_name_source":null,"issuer_url":"/issuer/0000887936","owner_cik":"0001280180","owner_name":"JACOBY PHILIP R JR","owner_url":"/insider/0001280180","role":"Officer (VP and Corporate Controller)","officer_title":"VP and Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.22,"price_display":"16.22","price_state":"stated","total_value":16220.0,"total_display":"16,220.00","shares_owned_after":69.0,"shares_owned_after_display":"69","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-09","filed_date":"2004-08-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001360886","name":"OSIRIS THERAPEUTICS, INC.","url":"/issuer/0001360886","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2013-11-26","last_seen":"2015-05-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000887936","name":"FTI CONSULTING INC","url":"/issuer/0000887936","role":"Officer (VP and Corporate Controller)","n_filings":2,"first_seen":"2004-08-09","last_seen":"2004-11-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001280180","retrieved_at":"2026-08-22T04:15:35+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}